UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

Blood, 2009-04, Vol.113 (14), p.3154-3160

2009

Link zum Volltext

Verfügbarkeit prüfen

The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?

Transfusion medicine reviews, 2008-04, Vol.22 (2), p.103-116

2008

Link zum Volltext

Verfügbarkeit prüfen

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

Blood, 2007-01, Vol.109 (1), p.155-158

2007

Link zum Volltext

Verfügbarkeit prüfen

Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway

PloS one, 2013-08, Vol.8 (8), p.e71882-e71882

2013

Link zum Volltext

Verfügbarkeit prüfen

Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

Nature medicine, 2006-06, Vol.12 (6), p.688-692

2006

Link zum Volltext

Verfügbarkeit prüfen

Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo

Blood, 2006-01, Vol.107 (2), p.637-641

2006

Link zum Volltext

Verfügbarkeit prüfen

IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity

British journal of haematology, 2001-12, Vol.115 (3), p.679-686

2001

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside

Seminars in hematology, 2016-04, Vol.53, p.S20-S22

2016

Link zum Volltext

Verfügbarkeit prüfen

CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption

Transfusion (Philadelphia, Pa.), 2015-06, Vol.55 (6pt2), p.1492-1500

2015

Link zum Volltext

Verfügbarkeit prüfen

The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody–mediated amelioration of murine immune thrombocytopenia

Blood, 2011-12, Vol.118 (24), p.6403-6406

2011

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia

Pediatric Blood & Cancer, 2006-10, Vol.47 (S5), p.710-713

2006

Link zum Volltext

Verfügbarkeit prüfen

IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity

Blood, 2003-07, Vol.102 (2), p.558-560

2003

Link zum Volltext

Verfügbarkeit prüfen

Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?

Blood, 2011-01, Vol.117 (3), p.971-974

2011

Link zum Volltext

Verfügbarkeit prüfen

Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model

Transfusion (Philadelphia, Pa.), 2010-09, Vol.50 (9), p.2016-2025

2010

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg

Blood, 2005-02, Vol.105 (4), p.1546-1548

2005

Link zum Volltext

Verfügbarkeit prüfen

IgG‐mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti‐D in the prevention of haemolytic disease of the newborn?

British journal of haematology, 2007-10, Vol.139 (2), p.275-279

2007

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG

Blood, 2003-05, Vol.101 (9), p.3708-3713

2003

Link zum Volltext

Verfügbarkeit prüfen

Transfusion of IgG-Opsonized Foreign Red Blood Cells Mediates Reduction of Antigen-Specific B Cell Priming in a Murine Model

The Journal of immunology (1950), 2008-07, Vol.181 (2), p.948-953

2008

Link zum Volltext

Verfügbarkeit prüfen

Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn

Immunology, 2008-05, Vol.124 (1), p.141-146

2008

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of action of IVIG and anti-D in ITP

Transfusion and apheresis science, 2003-06, Vol.28 (3), p.249-255

2003

Link zum Volltext

Verfügbarkeit prüfen

Amelioration of Immune Thrombocytopenia in Human CD44 Transgenic Mice By Anti-Human CD44 Antibodies

Blood, 2016-12, Vol.128 (22), p.167-167

2016

Link zum Volltext

Verfügbarkeit prüfen

CD44 Antibody Mediated Amelioration of Murine ITP: Evidence for a Similar Strain Dependent FcγRIIB Requirement As Compared to Ivig

Blood, 2012-11, Vol.120 (21), p.1084-1084

2012

Link zum Volltext

Verfügbarkeit prüfen

Ivig, but Not a Monoclonal Anti-RBC Antibody, Requires the Presence of Gr-1+ Cells to Ameliorate Immune Thrombocytopenia in a Murine Model

Blood, 2012-11, Vol.120 (21), p.268-268

2012

Link zum Volltext

Verfügbarkeit prüfen

CD 44 antibody–mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of Fc γRIIb genetic disruption

Transfusion (Philadelphia, Pa.), 2015-06, Vol.55 (6pt2), p.1492-1500

2015

Link zum Volltext

Verfügbarkeit prüfen

Understanding platelet function through signal transduction

Transfusion medicine reviews, 2003, Vol.17 (1), p.45-56

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(131)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(64)
Humans
(52)
Animals
(34)
Female
(32)
Mice
(32)
Biological And Medical Sciences
(25)
Hematology
(24)
Medical Sciences
(22)
Male
(21)
Adult
(13)
Genetics & Heredity
(13)
Mice, Inbred C57bl
(13)
Immunoglobulins, Intravenous - Therapeutic Use
(12)
Middle Aged
(11)
Child
(10)
Genetics
(10)
Hematologic And Hematopoietic Diseases
(10)
Purpura, Thrombocytopenic, Idiopathic - Immunology
(10)
Disease Models, Animal
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway

Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo

IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity

Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside

CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption

The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody–mediated amelioration of murine immune thrombocytopenia

Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia

IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity

Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?

Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model

Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg

IgG‐mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti‐D in the prevention of haemolytic disease of the newborn?

Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG

Transfusion of IgG-Opsonized Foreign Red Blood Cells Mediates Reduction of Antigen-Specific B Cell Priming in a Murine Model

Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn

Mechanism of action of IVIG and anti-D in ITP

Amelioration of Immune Thrombocytopenia in Human CD44 Transgenic Mice By Anti-Human CD44 Antibodies

CD44 Antibody Mediated Amelioration of Murine ITP: Evidence for a Similar Strain Dependent FcγRIIB Requirement As Compared to Ivig

Ivig, but Not a Monoclonal Anti-RBC Antibody, Requires the Presence of Gr-1+ Cells to Ameliorate Immune Thrombocytopenia in a Murine Model

CD 44 antibody–mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of Fc γRIIb genetic disruption

Understanding platelet function through signal transduction

Suchergebnisse filtern